About Us

Burrage Capital is a long-short equity manager focused in biotechnology and medical technology. Burrage Capital uses in-depth medical and industry research to identify undervalued small and mid-cap companies which are developing compelling drugs and medical technologies.

Strategies

Burrage Capital focuses on finding meaningful drugs and technologies which offer transformative outcomes for patients. The investment process at Burrage Capital is driven by deep medical research and clinical insight. The idea generation and due diligence process is focused on the review of scientific, clinical and medical practice data. Because of Dr. Bardon’s long-term relationships with the medical, scientific and biotechnology community, Burrage Capital has a unique ability to understand and find drugs and technologies which will have a meaningful impact for patients to generate investor returns.

Burrage Capital identifies these companies when they are at their small and mid-cap stages, before they have achieved broad investor acceptance. Burrage Capital works across all therapeutic areas but has a special focus in cancer, which represents the most compelling area of investment within biotechnology.

Meet Our Team

Christiana Goh Bardon, MD

Managing Member and
Portfolio Manager

Howard B. Rubin, CFA

Chief Operating Officer

Jeff Crispen

Chief Financial Officer and
Chief Compliance Officer

Briggs Morrison, MD

Investment Partner

Leigh Zawel

Investment Partner

Joshua Harrison

Research Assistant

Jay Bosse

Director of Operations

Contact Us

Burrage Capital

314 Commonwealth Ave
4th Floor
Boston, MA 02115

617-410-4770